ARYA Atherosclerosis Journal

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Mid-term follow-up of COVID-19 patients with permanent pacemaker implantation due to bradyarrhythmia at the acute phase of infection

Document Type : Case Series

Authors

1 Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

2 Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Cardiology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Abstract

BACKGROUND: Arrhythmia is one of the important cardiac manifestations of SARS-CoV-2 disease with possible mechanisms such as direct damage to the myocardium, hypoxia, myocardial damage, cytokine storm, and electrolyte imbalances. Bradyarrhythmia is a manifestation of conduction system involvement, which is associated with an unfavorable prognosis and sometimes requires treatments such as implanting a pacemaker. Whether bradycardia in the acute phase of the COVID pandemic is a transient complication of the virus or whether it will be permanent can affect the treatment approach.
Is the effect of SARS-CoV-2 on the conduction system of the heart temporary or permanent, and in the one-year follow-up, how many patients will need a pacemaker?
METHODS: The study population was among patients with symptomatic bradyar-rhythmias who were referred to Chamran Heart Center, Isfahan, Iran, from the outbreak of SARS-CoV-2 (February 2020) until February 2022 and were diagnosed with COVID-19 based on the polymerase chain reaction (PCR) test. They underwent permanent pacemaker implantation and were monitored for 1 month and 12 months after device implantation.
RESULTS: The most common comorbid disease was hypertension. Systolic blood pressure and respiratory rate in hospitalized patients decreased significantly during discharge. Also, oxygen saturation and heart rate increased significantly during discharge (P < 0.001). In this study, high-degree atrioventricular block remained permanent in most patients and was not transient.
CONCLUSION: Based on the experiences gained from this study, the implantation of a permanent pacemaker for the treatment of bradyarrhythmia should be done based on the existing guidelines, regardless of the status of COVID-19.

Keywords

References
1. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 Jul 1;5(7):831-40. https://doi.org/10.1001/jamacardio.2020.1286
2. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar;19(3):141-54. https://doi.org/10.1038/s41579-020-00459-7
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585
4. Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infect. 2000 Dec;6(12):633-4. https://doi.org/10.1046/j.1469-0691.2000.0194f.x
5. Ikeuchi K, Saito M, Yamamoto S, Nagai H, Adachi E. Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerg Infect Dis. 2020 Oct;26(10):2504-6. https://doi.org/10.3201/eid2610.202648
6. Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman TJ, Turagam M, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. 2020 Sep;17(9):e233-41. https://doi.org/10.1016/j.hrthm.2020.03.028
7. Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med. 2020;2(9):1430-5. https://doi.org/10.1007/s42399-020-00454-2
8. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020 Apr 29;33(5):373-4. https://doi.org/10.1093/ajh/hpaa057
9. McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. https://doi.org/10.1016/s2213-8587(20)30405-8
10. Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021 Jan 12;143(2):135-44. https://doi.org/10.1161/circulationaha.120.051936
11. Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol. 2020 Sep;6(9):1193-1204. https://doi.org/10.1016/j.jacep.2020.08.002
12. Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020 Nov;59(2):329-36. https://doi.org/10.1007/s10840-020-00789-9
13. Akhtar Z, Leung LW, Kontogiannis C, Zuberi Z, Bajpai A, Sharma S, et al. Prevalence of bradyarrhythmias needing pacing in COVID-19. Pacing Clin Electrophysiol. 2021 Aug;44(8):1340-6. https://doi.org/10.1111/pace.14313
14. Lilly LS. Braunwald’s Heart Disease Review and Assessment E-Book: A Companion to Braunwald’s Heart Disease. Elsevier Health Sciences; 2022 Aug 13:1751-65.
15. Chinitz JS, Goyal R, Harding M, Veseli G, Gruberg L, Jadonath R, et al. Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis? Pacing Clin Electrophysiol. 2020 Oct;43(10):1199-204. https://doi.org/10.1111/pace.14042
16. Nagamine T, Randhawa S, Nishimura Y, Huang R, Leesutipornchai T, Benavente K, et al. Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review. Pacing Clin Electrophysiol. 2022 Apr;45(4):556-66. https://doi.org/10.1111/pace.14466
17. Shahabi J, Askari M, Azhari A, Kermani-Alghoraishi M. The survey of electrophysiology lab activity during the COVID-19 pandemic. J Arrhythm. 2021 Jun 24;37(4):899-903. https://doi.org/10.1002/joa3.12584
18. Akhtar Z, Montalbano N, Leung LWM, Gallagher MM, Zuberi Z. Drive-Through Pacing Clinic: A Popular Response to the COVID-19 Pandemic. JACC Clin Electrophysiol. 2021 Jan;7(1):128-30. https://doi.org/10.1016/j.jacep.2020.09.026
19. Dagher L, Wanna B, Mikdadi G, Young M, Sohns C, Marrouche NF. High-degree atrioventricular block in COVID-19 hospitalized patients. Europace. 2021 Mar 8;23(3):451-55. https://doi.org/10.1093/europace/euaa333
20. Eneizat Mahdawi T, Wang H, Haddadin FI, Al-Qaysi D, Wylie JV. Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2. HeartRhythm Case Rep. 2020 Sep;6(9):652-6. https://doi.org/10.1016/j.hrcr.2020.06.014
21. Zoob M, Smith Ks. The Aetiology of Complete Heart-Block. Br Med J. 1963 Nov 9;2(5366):1149-53. https://doi.org/10.1136/bmj.2.5366.1149
22. Kennebäck G, Tabrizi F, Lindell P, Nordlander R. High-degree atrioventricular block during anti-arrhythmic drug treatment: use of a pacemaker with a bradycardia-detection algorithm to study the time course after drug withdrawal. Europace. 2007 Mar;9(3):186-91. https://doi.org/10.1093/europace/eul185
23. Yesil M, Bayata S, Arikan E, Yilmaz R, Postaci N. Should we revascularize before implanting a pacemaker? Clin Cardiol. 2008 Oct;31(10):498-501. https://doi.org/10.1002/clc.20280
24. Palmisano P, Ziacchi M, Ammendola E, Dell’Era G, Guerra F, Aspromonte V, et al. Long-term progression of rhythm and conduction disturbances in pacemaker recipients: findings from the Pacemaker Expert Programming study. J Cardiovasc Med (Hagerstown). 2018 Jul;19(7):357-65. https://doi.org/10.2459/jcm.0000000000000673
26. Umeh C, Giberson C, Kumar S, Aseri M, Barve P. A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients. Cureus. 2022 Jan 16;14(1):e21294. https://doi.org/10.7759/cureus.21294
27. Taylor MR, Gaco D. Symptomatic sinus bradycardia after a treatment course of high-dose oral prednisone. J Emerg Med. 2013 Sep;45(3):e55-8. https://doi.org/10.1016/j.jemermed.2013.04.020
28. Akikusa JD, Feldman BM, Gross GJ, Silverman ED, Schneider R. Sinus bradycardia after intravenous pulse methylprednisolone. Pediatrics. 2007 Mar;119(3):e778-82. https://doi.org/10.1542/peds.2006-0029
29. Stroeder J, Evans C, Mansell H. Corticosteroid-induced bradycardia: Case report and review of the literature. Can Pharm J (Ott). 2015 Sep;148(5):235-40. https://doi.org/10.1177/1715163515597451
30. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000 Feb;21(1):55-89. https://doi.org/10.1210/edrv.21.1.0389
31. Durrani M, Haq IU, Kalsoom U, Yousaf A. Chest X-rays findings in COVID 19 patients at a University Teaching Hospital - A descriptive study. Pak J Med Sci. 2020 May;36(COVID19-S4):S22-6. https://doi.org/10.12669/pjms.36.covid19-s4.2778
32. Davies AO, Lefkowitz RJ. Regulation of beta-adrenergic receptors by steroid hormones. Annu Rev Physiol. 1984;46:119-30. https://doi.org/10.1146/annurev.ph.46.030184.001003
33. Bassi R, Ismail Z, Salabei JK, Charles K, Haider AA, Hussein A, et al. COVID-19-Induced Complete Heart Block: Case Series and Literature Review. Cureus. 2023 Apr 13;15(4):e37517. https://doi.org/10.7759/cureus.37517
ARYA Atherosclerosis Journal
Volume 21, Issue 1
January and February 2025
Pages 7-14
Files
Share
How to cite
Statistics